Premium
IBRUTINIB DECREASES OBINUTUZUMAB‐INDUCED SECRETION OF CYTOKINES ASSOCIATED WITH INFUSION‐RELATED REACTIONS IN PATIENTS WITH CLL: ANALYSIS FROM THE ILLUMINATE STUDY
Author(s) -
Greil R.,
Tedeschi A.,
Moreno C.,
Anz B.,
Larratt L.,
Simkovic M.,
Gill D.,
Gribben J.G.,
Flinn I.W.,
Wang Z.,
Cheung L.W.,
Nguyen A.N.,
Zhou C.,
Styles L.,
Demirkan F.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.27_2630
Subject(s) - medicine , obinutuzumab , ibrutinib , fludarabine , chronic lymphocytic leukemia , cytokine , gastroenterology , neutropenia , pharmacology , immunology , leukemia , chemotherapy , cyclophosphamide